Cytophage Technologies Ltd. (TSXV:CYTO)

Canada flag Canada · Delayed Price · Currency is CAD
0.1850
+0.0050 (2.78%)
Jul 4, 2025, 4:00 PM EDT
-49.32%
Market Cap 11.41M
Revenue (ttm) n/a
Net Income (ttm) -4.74M
Shares Out 61.69M
EPS (ttm) -0.09
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 37,513
Open 0.1800
Previous Close 0.1800
Day's Range 0.1800 - 0.1850
52-Week Range 0.1250 - 0.3950
Beta 0.09
RSI 45.28
Earnings Date Aug 29, 2025

About Cytophage Technologies

Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops poultry health products under the AviPhage name; food safety products under the PhageFend name; bovine mastitis products under the BoviPhage name; and water-soluble solution for livestock producers under the FarmPhage name. The company is headquartered in Oak Bluff, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Steven Theriault
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol CYTO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.